Increlex
Increlex ingredients
| Active ingredient | Strength |
|---|---|
| Mecasermin | 40 mg/4mL |
What Increlex is used for
The FDA lists the approved uses on the official label (below). In the EU, mecasermin is approved as Increlex for:
For the long-term treatment of growth failure in children and adolescents with severe primary insulin-like-growth-factor-1 deficiency (primary IGFD). Severe primary IGFD is defined by: height standard deviation score … (the exact criteria are in the official EMA product information).
EU wording from the European Medicines Agency; US approved uses can differ.
Key facts
- Brand
- Increlex
- Generic name
- Mecasermin
- Made by
- Eton Pharmaceuticals, Inc.
- Forms
- Injection, Injection, Solution
- Given
- Subcutaneous
- FDA approval
- Biologic licence (BLA) BLA021839
- On the US market since
- 2006
Official information
- Increlex prescribing information (FDA label) on DailyMed
- MedlinePlus drug information (search for Mecasermin)
Specialist medicine: started and supervised by a specialist doctor or hospital. This page is a plain-language summary of public official information, not medical advice; follow your doctor and the official product information.
Common questions
What is Increlex?
Increlex (Mecasermin) is a specialist medicine made by Eton Pharmaceuticals, Inc., approved by the US FDA.
What are the ingredients of Increlex?
Increlex contains Mecasermin (40 mg/4mL).
Is Increlex approved in Europe?
The same active substance is approved in the EU as Increlex.
From the FDA National Drug Code directory (open.fda.gov, public domain) and the European Medicines Agency medicines list. Page made 5 November 2026 by Satya Babu.
← All specialty medicines, USA